Glycosylation in health and disease

The glycome describes the complete repertoire of glycoconjugates composed of carbohydrate chains, or glycans, that are covalently linked to lipid or protein molecules. Glycoconjugates are formed through a process called glycosylation and can differ in their glycan sequences, the connections between them and their length. Glycoconjugate synthesis is a dynamic process that depends on the local milieu of enzymes, sugar precursors and organelle structures as well as the cell types involved and cellular signals. Studies of rare genetic disorders that affect glycosylation first highlighted the biological importance of the glycome, and technological advances have improved our understanding of its heterogeneity and complexity. Researchers can now routinely assess how the secreted and cell-surface glycomes reflect overall cellular status in health and disease. In fact, changes in glycosylation can modulate inflammatory responses, enable viral immune escape, promote cancer cell metastasis or regulate apoptosis; the composition of the glycome also affects kidney function in health and disease. New insights into the structure and function of the glycome can now be applied to therapy development and could improve our ability to fine-tune immunological responses and inflammation, optimize the performance of therapeutic antibodies and boost immune responses to cancer. These examples illustrate the potential of the emerging field of ‘glycomedicine’.Glycosylation refers to the addition of carbohydrate chains to proteins and lipids. In this Review, the authors discuss the broad role of glycans in immunity, cancer, xenotransplantation and glomerular filtration and the potential of ‘glycomedicine’.Key pointsGlycosylation is critical for physiological and pathological cellular functions; advances in analytical techniques have driven progression in the field of glycobiology over the past decade.Congenital disorders of glycosylation have provided considerable insight into basic mechanisms underlying the associations of specific glycoconjugates with disease phenotypes.Interactions between immune cells that are mediated by cell surface molecules and drive cellular activation are regulated by the glycosylation motifs of membrane-bound glycoconjugates and their binding to sugar-specific receptors.Cancers often exhibit oncofetal phenotypes that are reflected in the nature of their glycoconjugates; these changes in glycosylation drive metastatic properties, inhibition of apoptosis and resistance to chemotherapy.The pathogenesis of many autoimmune diseases, such as immunoglobulin A (IgA) nephropathy, systemic lupus erythematosus and inflammatory bowel disease, involves abnormal glycosylation of one or more glycoproteins; diabetes involves abnormal O-linked N-acetylglucosamine-mediated signalling and enhanced glycation of multiple proteins.Immunoglobulin glycosylation controls the effector functions of antibodies, which creates opportunities for the therapeutic application of glycoengineering.

[1]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[2]  D. Adu,et al.  Hypogalactosylation of serum IgG in patients with ANCA‐associated systemic vasculitis , 2002, Clinical and experimental immunology.

[3]  T. Okada,et al.  Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Maxfield,et al.  Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells Published, JLR Papers in Press, November 15, 2005. , 2006, Journal of Lipid Research.

[5]  Neal Young,et al.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria. , 2005, Blood.

[6]  T. Okamoto,et al.  Effect of five-membered sugar mimics on mammalian glycogen-degrading enzymes and various glucosidases. , 2008, Bioorganic & medicinal chemistry.

[7]  R. L. Lieberman,et al.  Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability. , 2009, Biochemistry.

[8]  Jenny Nyström,et al.  Properties of the Glomerular Barrier and Mechanisms of Proteinuria , 2022 .

[9]  J. Rubinstein,et al.  Molecular basis of human CD22 function and therapeutic targeting , 2017, Nature Communications.

[10]  M. Hoshijima,et al.  Adenovirus-Mediated Overexpression of O-GlcNAcase Improves Contractile Function in the Diabetic Heart , 2005, Circulation research.

[11]  R. Dwek,et al.  Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation. , 2003, The Biochemical journal.

[12]  J. Hauber,et al.  The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection , 2009, Proceedings of the National Academy of Sciences.

[13]  P. James,et al.  N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models , 2016, Clinical Proteomics.

[14]  H. Scher,et al.  Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Takeshita,et al.  Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. , 1993, The Journal of biological chemistry.

[16]  K. Hanada,et al.  CERT and intracellular trafficking of ceramide. , 2007, Biochimica et biophysica acta.

[17]  Pauline M. Rudd,et al.  Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer , 2018, Molecular oncology.

[18]  D. Scott,et al.  Heterogenic Endothelial Responses to Inflammation: Role for Differential N‐Glycosylation and Vascular Bed of Origin , 2013, Journal of the American Heart Association.

[19]  Deepika Vasudevan,et al.  Novel roles for O-linked glycans in protein folding , 2014, Glycoconjugate Journal.

[20]  G. Millat,et al.  Structure and function of the NPC2 protein. , 2004, Biochimica et biophysica acta.

[21]  M. Tsai,et al.  Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells. , 2016, Cancer research.

[22]  B. Volkman,et al.  Biosynthesis of D-alanyl-lipoteichoic acid: the tertiary structure of apo-D-alanyl carrier protein. , 2001, Biochemistry.

[23]  Xiaobo Song,et al.  Modification of Sialylation Mediates the Invasive Properties and Chemosensitivity of Human Hepatocellular Carcinoma. , 2014, Molecular & cellular proteomics : MCP.

[24]  L. Hong,et al.  Anti‐diabetic effect of an α‐glucan from fruit body of maitake (Grifola frondosa) on KK‐Ay mice , 2007 .

[25]  D. Borza Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[26]  B. Maras,et al.  Structural Analysis of Saposin C and B , 1995, The Journal of Biological Chemistry.

[27]  K. Matsui,et al.  Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents. , 1986, Journal of medicinal chemistry.

[28]  Chi‐Huey Wong,et al.  A common glycan structure on immunoglobulin G for enhancement of effector functions , 2015, Proceedings of the National Academy of Sciences.

[29]  M. Weinblatt,et al.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[30]  J. Rhodes,et al.  Altered glycosylation in inflammatory bowel disease: A possible role in cancer development , 2001, Glycoconjugate Journal.

[31]  F. Grahammer,et al.  The podocyte slit diaphragm—from a thin grey line to a complex signalling hub , 2013, Nature Reviews Nephrology.

[32]  S. Iida,et al.  The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation , 2008, Glycobiology.

[33]  W. Greene,et al.  The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus Infection , 2008, Journal of Virology.

[34]  A. V. van Zonneveld,et al.  Cloning of a cDNA Encoding Chitotriosidase, a Human Chitinase Produced by Macrophages (*) , 1995, The Journal of Biological Chemistry.

[35]  G. Springer T and Tn, general carcinoma autoantigens. , 1984, Science.

[36]  C. Landen,et al.  ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells , 2013, Journal of Ovarian Research.

[37]  M. Tector,et al.  Evaluation of human and non‐human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes , 2015, Xenotransplantation.

[38]  R. Moriarty,et al.  exo-Imino to endo-iminocyclitol rearrangement. A general route to five-membered antiviral azasugars. , 2006, Organic letters.

[39]  Christoph Grundner,et al.  Tyrosine Sulfation of Human Antibodies Contributes to Recognition of the CCR5 Binding Region of HIV-1 gp120 , 2003, Cell.

[40]  O. Wiest,et al.  Investigation of N-aryl-3-alkylidenepyrrolinones as potential Niemann-Pick type C disease therapeutics. , 2009, Journal of medicinal chemistry.

[41]  R. Linhardt,et al.  Heparin‐Protein‐Wechselwirkungen , 2002 .

[42]  Ian A Wilson,et al.  Structure and Immune Recognition of the HIV Glycan Shield. , 2018, Annual review of biophysics.

[43]  M. Brockhaus,et al.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. , 1982, The Journal of biological chemistry.

[44]  Henrik Clausen,et al.  Location, location, location: new insights into O-GalNAc protein glycosylation. , 2011, Trends in cell biology.

[45]  K. Sandhoff,et al.  Sphingolipid metabolism diseases. , 2006, Biochimica et biophysica acta.

[46]  M. Salvatore,et al.  Effects of enzyme-replacement therapy in patients with Anderson–Fabry disease: a prospective long-term cardiac magnetic resonance imaging study , 2009, Heart.

[47]  R. Laine,et al.  A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 x 10(12) structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. , 1994, Glycobiology.

[48]  R. Marchase,et al.  Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. , 2007, American journal of physiology. Cell physiology.

[49]  E. Vassella,et al.  Major Surface Glycoproteins of Insect Forms of Trypanosoma brucei Are Not Essential for Cyclical Transmission by Tsetse , 2009, PloS one.

[50]  E. De Clercq,et al.  Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus , 1988, Antimicrobial Agents and Chemotherapy.

[51]  R. Langer,et al.  Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome , 2017, Oncotarget.

[52]  Y. Eto,et al.  Influence of antibody formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry patients during agalsidase beta therapy. , 2007, Molecular genetics and metabolism.

[53]  Masato Tanaka,et al.  Intestinal CD169+ macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes , 2015, Nature Communications.

[54]  G. Melikyan,et al.  Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1 , 2017, PLoS pathogens.

[55]  D. Tsuji,et al.  Production of Recombinant β-Hexosaminidase A, a Potential Enzyme for Replacement Therapy for Tay-Sachs and Sandhoff Diseases, in the Methylotrophic Yeast Ogataea minuta , 2007, Applied and Environmental Microbiology.

[56]  R. Langer,et al.  Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome , 2017, Oncotarget.

[57]  Roland Jakob-Roetne,et al.  Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen , 2009 .

[58]  P. Stanley Golgi glycosylation. , 2011, Cold Spring Harbor Perspectives in Biology.

[59]  H. Takematsu,et al.  CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice , 2018, Front. Immunol..

[60]  K. Yasuda,et al.  Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). , 2001, Journal of agricultural and food chemistry.

[61]  E. Morava,et al.  CDG Therapies: From Bench to Bedside , 2018, International journal of molecular sciences.

[62]  L. Svennerholm CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.

[63]  D. Mavilio,et al.  Host Immune Responses in HIV-1 Infection: The Emerging Pathogenic Role of Siglecs and Their Clinical Correlates , 2017, Front. Immunol..

[64]  J. Gready,et al.  Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. , 2000, Biochemistry.

[65]  S. Withers,et al.  Identification of Asp-130 as the catalytic nucleophile in the main alpha-galactosidase from Phanerochaete chrysosporium, a family 27 glycosyl hydrolase. , 2000, Biochemistry.

[66]  G. Schwarzmann,et al.  Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis. , 1994, European journal of biochemistry.

[67]  S. Prusiner,et al.  Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[68]  L. Pike Rafts defined: a report on the Keystone symposium on lipid rafts and cell function Published, JLR Papers in Press, April 27, 2006. , 2006, Journal of Lipid Research.

[69]  R. Bayer,et al.  GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. , 2006, Glycobiology.

[70]  J. Taylor‐Papadimitriou,et al.  The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer* , 2006, Journal of Biological Chemistry.

[71]  Luft Jh Fine structures of capillary and endocapillary layer as revealed by ruthenium red. , 1966 .

[72]  T. Dierks,et al.  Multiple Sulfatase Deficiency Is Caused by Mutations in the Gene Encoding the Human Cα-Formylglycine Generating Enzyme , 2003, Cell.

[73]  P. Seeberger,et al.  Semisynthese eines Glycosylphosphatidylinositol‐verankerten Prionproteins , 2008 .

[74]  E. Vimr,et al.  In vivo enzymatic removal of alpha 2-->6-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[75]  J. Ravetch,et al.  Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway , 2011, Nature.

[76]  R. Dwek,et al.  N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. , 1994, The Journal of biological chemistry.

[77]  D. Werz,et al.  Automated synthesis of the tumor-associated carbohydrate antigens Gb-3 and Globo-H: incorporation of alpha-galactosidic linkages. , 2007, Journal of the American Chemical Society.

[78]  A. Rops,et al.  Heparanase in glomerular diseases. , 2007, Kidney international.

[79]  Debabrata Ghosh,et al.  Hyposialylated IgG activates endothelial IgG receptor Fc&ggr;RIIB to promote obesity-induced insulin resistance , 2017, The Journal of clinical investigation.

[80]  S. Vilaró,et al.  Syndecan-2 downregulation impairs angiogenesis in human microvascular endothelial cells. , 2009, Experimental cell research.

[81]  A. Pshezhetsky,et al.  Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells* , 2004, Journal of Biological Chemistry.

[82]  L. Lasky Selectin-carbohydrate interactions and the initiation of the inflammatory response. , 1995, Annual review of biochemistry.

[83]  Masato Tanaka,et al.  CD169+ macrophages orchestrate innate immune responses by regulating bacterial localization in the spleen , 2017, Science Immunology.

[84]  D. Gin,et al.  Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines , 2007, Nature.

[85]  V. Zoldoš,et al.  Glyco-genes change expression in cancer through aberrant methylation. , 2016, Biochimica et biophysica acta.

[86]  J. Gariépy,et al.  Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer , 2016, Cancer Immunology Research.

[87]  F. Bard,et al.  Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes , 2010, The Journal of cell biology.

[88]  Liping Zhang,et al.  Enzymatic insights into an inherited genetic disorder , 2017, eLife.

[89]  A. Frasch,et al.  Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. , 2000, Parasitology today.

[90]  W. Massey,et al.  Scanning electron microscopy of incinerated teeth. , 1987, The American journal of forensic medicine and pathology.

[91]  F. Guadagni,et al.  TAG‐72 (CA 72‐4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer , 1993, Cancer.

[92]  Sara M. Butterfield,et al.  Wechselwirkungen zwischen amyloidogenen Proteinen und Membranen: Modellsysteme liefern mechanistische Einblicke , 2010 .

[93]  R. Shapiro,et al.  Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. , 1978, The Journal of biological chemistry.

[94]  P. Pour,et al.  Blood group specificity of pancreatic tumor mucin. , 1980, Cancer letters.

[95]  N. Asano Sugar-mimicking glycosidase inhibitors: bioactivity and application , 2009, Cellular and Molecular Life Sciences.

[96]  J. Hörber,et al.  Sphingolipid–Cholesterol Rafts Diffuse as Small Entities in the Plasma Membrane of Mammalian Cells , 2000, The Journal of cell biology.

[97]  J. Fabry Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae) , 1898, Archiv für Dermatologie und Syphilis.

[98]  Y. Ikehara,et al.  Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[99]  S. Hakomori Tumor-associated glycolipid antigens defined by monoclonal antibodies. , 1983, Bulletin du cancer.

[100]  W. Yi,et al.  Enzymatic synthesis of tumor-associated carbohydrate antigen Globo-H hexasaccharide. , 2008, Organic letters.

[101]  J. Brender,et al.  Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion. , 2009, Biophysical journal.

[102]  W. Garvey,et al.  New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[103]  Denis R. Miller,et al.  A tribute to Sidney Farber – the father of modern chemotherapy , 2006, British journal of haematology.

[104]  Andreas Radbruch,et al.  SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome , 2016, RMD Open.

[105]  A. Varki,et al.  Evolutionary considerations in relating oligosaccharide diversity to biological function. , 1999, Glycobiology.

[106]  G. Hart,et al.  A novel cell surface trans-sialidase of trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells , 1991, Cell.

[107]  C. Galarza-Maldonado,et al.  Diagnosis and classification of rheumatoid arthritis. , 2014, Journal of autoimmunity.

[108]  M. Fukuda,et al.  Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.

[109]  J. van den Born,et al.  Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. , 1993, Kidney international.

[110]  Yasuhiro Nakagami,et al.  The protein disulfide isomerase AGR2 is essential for production of intestinal mucus , 2009, Proceedings of the National Academy of Sciences.

[111]  A. Edefonti,et al.  Fifteen years of research on nephrin: what we still need to know. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[112]  Rhoel R. Dinglasan,et al.  Insight into a Conserved Lifestyle: Protein-Carbohydrate Adhesion Strategies of Vector-Borne Pathogens , 2005, Infection and Immunity.

[113]  P. Uchil,et al.  Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection , 2015, Science.

[114]  T. Cooke,et al.  Electron microscopic morphology of immunoglobulin aggregates and their interactions in rheumatoid articular collagenous tissues. , 1978, Arthritis and rheumatism.

[115]  R. Cummings,et al.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[116]  T. Dierks,et al.  Molecular Basis for Multiple Sulfatase Deficiency and Mechanism for Formylglycine Generation of the Human Formylglycine-Generating Enzyme , 2005, Cell.

[117]  T. Sugiura,et al.  Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease. , 2003, Molecular genetics and metabolism.

[118]  Ian A Wilson,et al.  The HIV‐1 envelope glycoprotein structure: nailing down a moving target , 2017, Immunological reviews.

[119]  J. Lau,et al.  Extrinsic sialylation is dynamically regulated by systemic triggers in vivo , 2017, The Journal of Biological Chemistry.

[120]  T. Okamoto,et al.  Iminosugar-producing Thai medicinal plants. , 2005, Journal of natural products.

[121]  F. dall’Olio,et al.  Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling , 2018, International journal of molecular sciences.

[122]  F Yamamoto,et al.  Review: ABO blood group system—ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes , 2004, Immunohematology.

[123]  E. Brown,et al.  Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β‐Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry , 2008, Chembiochem : a European journal of chemical biology.

[124]  Joel L Sussman,et al.  Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease. , 2007, The Journal of biological chemistry.

[125]  J. Tardif,et al.  Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial , 2016, Journal of the American Heart Association.

[126]  S. Fischer,et al.  Translational Pharmacokinetics and Pharmacodynamics of an FcRn‐Variant Anti‐CD4 Monoclonal Antibody From Preclinical Model to Phase I Study , 2011, Clinical pharmacology and therapeutics.

[127]  C. Götting,et al.  Analysis of xylosyltransferase II binding to the anticoagulant heparin. , 2009, Biochemical and biophysical research communications.

[128]  C. Walsh,et al.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. , 2002, American journal of human genetics.

[129]  P. Freemont,et al.  Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS , 2009, Proceedings of the National Academy of Sciences.

[130]  M. Telen,et al.  Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia , 2014, PloS one.

[131]  F. Braet,et al.  Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier , 2009, American journal of physiology. Renal physiology.

[132]  Jyh‐cherng Yu,et al.  Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis , 2008, Proceedings of the National Academy of Sciences.

[133]  V. Zurawski,et al.  Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. , 1982 .

[134]  J. D. Capra,et al.  Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression. , 2009, Blood.

[135]  Peter D. Kwong,et al.  HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.

[136]  D. Dudziak,et al.  Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation , 2017, International immunology.

[137]  T. Becker,et al.  Vollsynthetische Vakzinen aus tumorassoziierten MUC1‐Glycopeptiden und einem Lipopeptid‐Liganden des Toll‐like Rezeptors 2 , 2010 .

[138]  T. Kinoshita,et al.  Molecular Genetics of Paroxysmal Nocturnal Hemoglobinuria , 2003, International journal of hematology.

[139]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[140]  C. Rider The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection , 1997, Glycoconjugate Journal.

[141]  Jin Hyo Kim,et al.  Sulfonamide chalcone as a new class of α-glucosidase inhibitors , 2005 .

[142]  R. Rosenberg,et al.  The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.

[143]  Andrew V. Nguyen,et al.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. , 2010, The American journal of pathology.

[144]  Ruud P. M. Dings,et al.  Galectins as Molecular Targets for Therapeutic Intervention , 2018, International journal of molecular sciences.

[145]  R. Dwek,et al.  Secretory IgA N- and O-Glycans Provide a Link between the Innate and Adaptive Immune Systems* , 2003, Journal of Biological Chemistry.

[146]  R. McEver A sulfated address for lymphocyte homing , 2005, Nature Immunology.

[147]  B. Sankaran,et al.  Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody , 2016, Proceedings of the National Academy of Sciences.

[148]  S. Tuske,et al.  Isofagomine Induced Stabilization of Glucocerebrosidase , 2008, Chembiochem : a European journal of chemical biology.

[149]  A. Zylicz,et al.  Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology , 2010, Nature.

[150]  J. Novak,et al.  Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection , 2014, AIDS Research and Therapy.

[151]  A. Ohta,et al.  Potentiation of antitumor effect of NKT cell ligand, α-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1 , 2004, Clinical & Experimental Metastasis.

[152]  Kazuhiko Yamamoto,et al.  Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis , 2016, Nature Communications.

[153]  R. Dwek,et al.  Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. , 2005, Glycobiology.

[154]  N. Giltiay,et al.  CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity , 2018, Front. Immunol..

[155]  A. Galeone,et al.  Tissue-specific regulation of BMP signaling by Drosophila N-glycanase 1 , 2017, eLife.

[156]  Christian Gieger,et al.  Genome-Wide Association Study on Immunoglobulin G Glycosylation Patterns , 2018, Front. Immunol..

[157]  R. Brady,et al.  Elevated globotriaosylsphingosine is a hallmark of Fabry disease , 2008, Proceedings of the National Academy of Sciences.

[158]  F. Roviello,et al.  Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. , 2001, American journal of surgery.

[159]  M. Textor,et al.  Untersuchung von Protein‐Chaperon‐Wechselwirkungen mit Einzelmolekülspektroskopie , 2008 .

[160]  D. Cooper,et al.  Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans , 2017, PloS one.

[161]  A. Frasch,et al.  Trypanosoma cruzi surface mucins: host-dependent coat diversity , 2006, Nature Reviews Microbiology.

[162]  B. Julian,et al.  Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes , 2013, The Journal of Biological Chemistry.

[163]  Richard D Cummings,et al.  Training the next generation of biomedical investigators in glycosciences. , 2016, The Journal of clinical investigation.

[164]  D. Abrahamson,et al.  Endothelial signal integration in vascular assembly. , 2000, Annual review of physiology.

[165]  J. Peter-Katalinic,et al.  The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies. , 1992, European journal of biochemistry.

[166]  A. Galione,et al.  Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium , 2008, Nature Medicine.

[167]  Roger A. Laine,et al.  Invited Commentary: A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 1012 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems , 1994 .

[168]  Q. Sattentau,et al.  Stabilized HIV-1 envelope glycoprotein trimers for vaccine use , 2017, Current opinion in HIV and AIDS.

[169]  Lawrence A Tabak,et al.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. , 2012, Glycobiology.

[170]  Henrik Clausen,et al.  Mucin-type O-glycosylation and its potential use in drug and vaccine development. , 2008, Biochimica et biophysica acta.

[171]  G. Alarcón,et al.  Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. , 1988, Arthritis and rheumatism.

[172]  Bruce Tidor,et al.  Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors , 2008, Proceedings of the National Academy of Sciences.

[173]  Allan C. deCamp,et al.  HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees , 2018, Journal of Virology.

[174]  Chiun-Sheng Huang,et al.  Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway , 2015, Oncotarget.

[175]  Norman L. Letvin,et al.  T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces , 2009, Journal of Virology.

[176]  D. Barouch,et al.  Challenges in the development of an HIV-1 vaccine , 2008, Nature.

[177]  S. Withers,et al.  The Search for Novel Human Pancreatic α‐Amylase Inhibitors: High‐Throughput Screening of Terrestrial and Marine Natural Product Extracts , 2008, Chembiochem : a European journal of chemical biology.

[178]  Xiaobo Song,et al.  Modification of Sialylation Mediates the Invasive Properties and Chemosensitivity of Human Hepatocellular Carcinoma* , 2013, Molecular & Cellular Proteomics.

[179]  R. Drake,et al.  N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging. , 2018, Journal of proteome research.

[180]  I. Wilson,et al.  T cells control the generation of nanomolar-affinity anti-glycan antibodies , 2017, The Journal of clinical investigation.

[181]  Thomas J. Raub,et al.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.

[182]  D. Beeler,et al.  6-O-Sulfotransferase-1 Represents a Critical Enzyme in the Anticoagulant Heparan Sulfate Biosynthetic Pathway* , 2001, The Journal of Biological Chemistry.

[183]  T. Spector,et al.  Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome , 2015, Arthritis & rheumatology.

[184]  J. Turnbull,et al.  Identification of the Heparan Sulfate Binding Sites in the Cellular Prion Protein* , 2002, The Journal of Biological Chemistry.

[185]  Ferdinando Chiaradonna,et al.  The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring , 2018, Cells.

[186]  Ajit Varki,et al.  Biological roles of glycans , 2016, Glycobiology.

[187]  A. Varki,et al.  Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. , 2007, Thrombosis research.

[188]  I. Mocchetti Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins , 2005, Cellular and Molecular Life Sciences CMLS.

[189]  J. Månsson,et al.  Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. , 1980, Journal of lipid research.

[190]  Q. Qian,et al.  Glucose Mediates the Translocation of NeuroD1 by O-Linked Glycosylation* , 2007, Journal of Biological Chemistry.

[191]  M. Falk,et al.  Mitochondrial function requires NGLY1. , 2018, Mitochondrion.

[192]  W. Boland,et al.  Thioglycosides as inhibitors of hSGLT1 and hSGLT2: Potential therapeutic agents for the control of hyperglycemia in diabetes , 2007, International journal of medical sciences.

[193]  P. Gallop,et al.  The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. , 1976, The Journal of clinical investigation.

[194]  R. Wagner,et al.  Particle-based delivery of the HIV envelope protein. , 2017, Current opinion in HIV and AIDS.

[195]  Lianyu Chen,et al.  Knockdown of FUT3 disrupts the proliferation, migration, tumorigenesis and TGF-β induced EMT in pancreatic cancer cells , 2018, Oncology letters.

[196]  F. Agakov,et al.  N-Glycan Profile and Kidney Disease in Type 1 Diabetes , 2017, Diabetes Care.

[197]  Pedro M Alzari,et al.  The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. , 2002, Molecular cell.

[198]  M. Fukuda,et al.  Sulfation of Colonic Mucins by N-Acetylglucosamine 6-O-Sulfotransferase-2 and Its Protective Function in Experimental Colitis in Mice* , 2009, The Journal of Biological Chemistry.

[199]  C. Yin,et al.  Diabetes Exacerbates Myocardial Ischemia/Reperfusion Injury by Down-Regulation of MicroRNA and Up-Regulation of O-GlcNAcylation , 2018, JACC. Basic to translational science.

[200]  A. Saremi,et al.  Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study , 2017, Diabetes Care.

[201]  Targeted genetic inactivation of N-acetylglucosaminyltransferase-IVa impairs insulin secretion from pancreatic beta cells and evokes type 2 diabetes. , 2010, Methods in enzymology.

[202]  Shuli Kang,et al.  Loss of GCNT2/I-branched glycans enhances melanoma growth and survival , 2018, Nature Communications.

[203]  J. Sancho,et al.  Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations. , 2005, Blood cells, molecules & diseases.

[204]  W. Greene,et al.  Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)* , 2009, The Journal of Biological Chemistry.

[205]  A. Imberty,et al.  Histo-blood group antigens as mediators of infections. , 2017, Current opinion in structural biology.

[206]  R. Schwarz,et al.  Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[207]  C. Burlak,et al.  Double knockout pigs deficient in N‐glycolylneuraminic acid and Galactose α‐1,3‐Galactose reduce the humoral barrier to xenotransplantation , 2013, Xenotransplantation.

[208]  W. Jusko,et al.  Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes , 2010, Journal of clinical pharmacology.

[209]  Jae-Min Lim,et al.  Regulation of Glycan Structures in Murine Embryonic Stem Cells , 2012, The Journal of Biological Chemistry.

[210]  H. Mischinger,et al.  TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions. , 1999, Anticancer research.

[211]  F. Inagaki,et al.  In vitro synthesis of disialoganglioside (GD1 alpha) from asialo-GM1 using sialyltransferases in rat liver Golgi vesicles. , 1994, European journal of biochemistry.

[212]  Nicolle H. Packer,et al.  Mucin‐type O‐glycosylation – putting the pieces together , 2010, The FEBS journal.

[213]  R. Laine,et al.  Thioglycosides Are Efficient Metabolic Decoys of Glycosylation that Reduce Selectin Dependent Leukocyte Adhesion. , 2018, Cell chemical biology.

[214]  L. Cooling Blood Groups in Infection and Host Susceptibility , 2015, Clinical Microbiology Reviews.

[215]  A. Paterson,et al.  Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death , 2000 .

[216]  A. Ballabio,et al.  The Multiple Sulfatase Deficiency Gene Encodes an Essential and Limiting Factor for the Activity of Sulfatases , 2003, Cell.

[217]  P. Deegan,et al.  Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. , 2005, Blood cells, molecules & diseases.

[218]  P. Orlean,et al.  A conditionally lethal yeast mutant blocked at the first step in glycosyl phosphatidylinositol anchor synthesis. , 1994, The Journal of biological chemistry.

[219]  M. Kiso,et al.  Transglycosylation-based fluorescent labeling of 6-gala series glycolipids by endogalactosylceramidase. , 2009, Glycobiology.

[220]  S. Kersten,et al.  Podocyte secreted Angiopoietin-like 4 mediates proteinuria in glucocorticoid sensitive nephrotic syndrome , 2010, Nature Medicine.

[221]  I. Vlodavsky,et al.  In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[222]  H. Freeze,et al.  Perspectives on Glycosylation and Its Congenital Disorders. , 2018, Trends in genetics : TIG.

[223]  Xi Jiang,et al.  Norovirus and Histo-Blood Group Antigens: Demonstration of a Wide Spectrum of Strain Specificities and Classification of Two Major Binding Groups among Multiple Binding Patterns , 2005, Journal of Virology.

[224]  Joel L Sussman,et al.  Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease. , 2006, Acta crystallographica. Section D, Biological crystallography.

[225]  O. Majdic,et al.  Engagement of distinct epitopes on CD43 induces different co‐stimulatory pathways in human T cells , 2016, Immunology.

[226]  N. Taniguchi,et al.  Metabolic control of T cell immune response through glycans in inflammatory bowel disease , 2018, Proceedings of the National Academy of Sciences.

[227]  Looking toward basic science for potential drug discovery targets against community‐associated MRSA , 2009, Medicinal research reviews.

[228]  U. Landegren,et al.  MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. , 2010, Glycobiology.

[229]  G. Bendas,et al.  Melanoma cell adhesion can be blocked by heparin in vitro: Suggestion of VLA-4 as a novel target for antimetastatic approaches , 2008, Thrombosis and Haemostasis.

[230]  J. Lünemann,et al.  Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity , 2017, Front. Immunol..

[231]  D. Ehrnhoefer,et al.  EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity , 2010, Proceedings of the National Academy of Sciences.

[232]  R. Sasisekharan,et al.  The Impact of Heparanese and Heparin on Cancer Metastasis and Angiogenesis , 2006, Pathophysiology of Haemostasis and Thrombosis.

[233]  T. Hartung,et al.  Synthetic Lipoteichoic Acid from Staphylococcus aureus Is a Potent Stimulus of Cytokine Release , 2002, The Journal of experimental medicine.

[234]  H. Yamada,et al.  Cytochemical and biochemical detection of intracellularly accumulated sialyl glycoconjugates in sialidosis and galactosialidosis fibroblasts with Macckia amurensis. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[235]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[236]  Aurora Martínez,et al.  Pharmacological Chaperoning: A Potential Treatment for PMM2‐CDG , 2017, Human mutation.

[237]  N. Samani,et al.  Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1. , 2017, Journal of the American Society of Nephrology : JASN.

[238]  S. Withers,et al.  Development of New and Selective Trypanosoma cruzi trans‐Sialidase Inhibitors from Sulfonamide Chalcones and Their Derivatives , 2009, Chembiochem : a European journal of chemical biology.

[239]  R. Cummings,et al.  Protein glycosylation: Chaperone mutation in Tn syndrome , 2005, Nature.

[240]  M. Estes,et al.  Diversity in Rotavirus–Host Glycan Interactions: A “Sweet” Spectrum , 2016, Cellular and molecular gastroenterology and hepatology.

[241]  Jian‐Qiang Fan A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity. , 2003, Trends in pharmacological sciences.

[242]  A. Weiss,et al.  An extracatalytic function of CD45 in B cells is mediated by CD22 , 2015, Proceedings of the National Academy of Sciences.

[243]  K. Drickamer,et al.  Ca(2+)-dependent sugar recognition by animal lectins. , 1996, Biochemical Society transactions.

[244]  S. Ōmura,et al.  Mechanism by which the lectin actinohivin blocks HIV infection of target cells , 2009, Proceedings of the National Academy of Sciences.

[245]  I. Ionita-Laza,et al.  GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway , 2016, bioRxiv.

[246]  Chi‐Huey Wong,et al.  Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids , 2007, Proceedings of the National Academy of Sciences.

[247]  L. Baum,et al.  T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival , 2012, Annals of the New York Academy of Sciences.

[248]  J. Meza,et al.  Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation , 2016, British Journal of Cancer.

[249]  T. Kohler,et al.  The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. , 2010, International journal of medical microbiology : IJMM.

[250]  H. Perreault,et al.  Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. , 2015, The Journal of clinical investigation.

[251]  J. Woof,et al.  Mucosal immunoglobulins , 2005, Immunological reviews.

[252]  S. Chung,et al.  The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms , 2006, Proceedings of the National Academy of Sciences.

[253]  P. Parren,et al.  Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen. , 2016, Molecular cell.

[254]  C. Belluco,et al.  Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients , 2000 .

[255]  T. Irimura,et al.  Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells. , 1986, Biochemistry.

[256]  P. Wesseling,et al.  Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques , 2002, Neurobiology of Aging.

[257]  G. Meijer,et al.  The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma , 2007, Cancer Immunology, Immunotherapy.

[258]  G. Zhai,et al.  Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes , 2017, PloS one.

[259]  A. Frasch,et al.  The action of Trypanosoma cruzi trans-sialidase on glycolipids and glycoproteins. , 1993, European journal of biochemistry.

[260]  J. Lau,et al.  Platelets Support Extracellular Sialylation by Supplying the Sugar Donor Substrate*♦ , 2014, The Journal of Biological Chemistry.

[261]  Ajit Varki,et al.  Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins , 2007, Nature.

[262]  C. Pérez-Cerdá,et al.  Protein misfolding diseases: Prospects of pharmacological treatment , 2018, Clinical genetics.

[263]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[264]  N Zitzmann,et al.  Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[265]  L. Earl,et al.  N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death* , 2009, The Journal of Biological Chemistry.

[266]  F. Lowy Staphylococcus aureus infections. , 2009, The New England journal of medicine.

[267]  P. Wesseling,et al.  Heparan sulphate proteoglycans in Alzheimer's disease and amyloid‐related disorders , 2003, The Lancet Neurology.

[268]  P. Zucchelli,et al.  [IgA nephropathy]. , 1985, Medicina clinica.

[269]  T. Dierks,et al.  Posttranslational Formation of Formylglycine in Prokaryotic Sulfatases by Modification of Either Cysteine or Serine* , 1998, The Journal of Biological Chemistry.

[270]  R. Kisilevsky,et al.  Sulfated glycosaminoglycans: a common constituent of all amyloids? , 1987, Laboratory investigation; a journal of technical methods and pathology.

[271]  G. Hansson,et al.  Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl‐Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL‐60 leukocyte adhesion to E‐selectin‐expressing endothelial cells , 1996, Journal of cellular biochemistry.

[272]  A. Zwinderman,et al.  Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. , 1994, British journal of rheumatology.

[273]  J. Sodroski,et al.  Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120 , 2000, Journal of Virology.

[274]  Giovanni Parmigiani,et al.  Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers , 2009, Proceedings of the National Academy of Sciences.

[275]  T Dierks,et al.  1.3 A structure of arylsulfatase from Pseudomonas aeruginosa establishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family. , 2001, Structure.

[276]  J. Novak,et al.  IgA nephropathy , 2016, Nature Reviews Disease Primers.

[277]  B. Imperiali,et al.  Bacterial phosphoglycosyl transferases: initiators of glycan biosynthesis at the membrane interface , 2017, Glycobiology.

[278]  T. Rabelink,et al.  Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease , 2017, Nature Reviews Nephrology.

[279]  Larry Norton,et al.  Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[280]  T. Hartung,et al.  Definition of Structural Prerequisites for Lipoteichoic Acid-Inducible Cytokine Induction by Synthetic Derivatives1 , 2003, The Journal of Immunology.

[281]  Brigitte E. Sanders-Beer,et al.  Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides , 2008, Antimicrobial Agents and Chemotherapy.

[282]  J. Lünemann,et al.  Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. , 2015, The Journal of clinical investigation.

[283]  R. Dwek,et al.  Productive Folding of Tyrosinase Ectodomain Is Controlled by the Transmembrane Anchor* , 2006, Journal of Biological Chemistry.

[284]  Jerome H. Kim,et al.  The HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development , 2014, Expert review of vaccines.

[285]  L. Dover,et al.  Lipoteichoic acid biosynthesis: two steps forwards, one step sideways? , 2009, Trends in microbiology.

[286]  F. Kirchhoff,et al.  Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection , 2007, Cell.

[287]  H. Freeze,et al.  Neurological aspects of human glycosylation disorders. , 2015, Annual review of neuroscience.

[288]  Wei Li,et al.  Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development , 2017, Front. Immunol..

[289]  D. Boakye,et al.  IgG1 Fc N-glycan galactosylation as a biomarker for immune activation , 2016, Scientific Reports.

[290]  A. Serafino,et al.  Saposin C induces pH‐dependent destabilization and fusion of phosphatidylserine‐containing vesicles , 1994, FEBS letters.

[291]  S Marshall,et al.  Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation. , 1991, The Journal of biological chemistry.

[292]  H. Lo,et al.  Submerged culture mycelium and broth of Grifola frondosa improve glycemic responses in diabetic rats. , 2008, The American journal of Chinese medicine.

[293]  T. Yankeelov,et al.  (cid:1) 2 (cid:2) 1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell–specific manner , 2022 .

[294]  L. Vaickus,et al.  Pharmacokinetics/Pharmacodynamics of Nondepleting Anti-CD4 Monoclonal Antibody (TRX1) in Healthy Human Volunteers , 2006, Pharmaceutical Research.

[295]  M. Tsai,et al.  O‐Glycosylation‐mediated signaling circuit drives metastatic castration‐resistant prostate cancer , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[296]  C. Ohyama,et al.  Core3 O-Glycan Synthase Suppresses Tumor Formation and Metastasis of Prostate Carcinoma PC3 and LNCaP Cells through Down-regulation of α2β1 Integrin Complex* , 2009, The Journal of Biological Chemistry.

[297]  J. Hartwig,et al.  The origin and function of platelet glycosyltransferases. , 2012, Blood.

[298]  H. Scher,et al.  Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer , 2005, Cancer Immunology, Immunotherapy.

[299]  A. Ooshima,et al.  Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling , 2013, Journal of Molecular Medicine.

[300]  R. Dwek,et al.  Agalactosyl glycoforms of IgG autoantibodies are pathogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[301]  M. Barone,et al.  The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[302]  Andrea Vasella,et al.  Neue Erkenntnisse über Hemmung, Struktur und Mechanismus konfigurationserhaltender Glycosidasen , 1999 .

[303]  J. Esko,et al.  The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.

[304]  Keiichiro Suzuki,et al.  IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria , 2018, The Journal of experimental medicine.

[305]  Daniel Kolarich,et al.  The role of glycosylation in IBD , 2014, Nature Reviews Gastroenterology &Hepatology.

[306]  N. Bhattacharyya,et al.  Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans , 2018, Nature Communications.

[307]  Roy Jefferis,et al.  Glycosylation as a strategy to improve antibody-based therapeutics , 2009, Nature Reviews Drug Discovery.

[308]  J. Moon,et al.  Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[309]  M. Wolfert,et al.  Robust immune responses elicited by a fully synthetic three-component vaccine. , 2007, Nature chemical biology.

[310]  S. Michel,et al.  Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease , 1992, Human Genetics.

[311]  J. Lau,et al.  Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation , 2017, Glycobiology.

[312]  L. Borsig Selectins facilitate carcinoma metastasis and heparin can prevent them. , 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[313]  L. Baum,et al.  Galectins and Immune Responses-Just How Do They Do Those Things They Do? , 2016, Annual review of immunology.

[314]  R. Dwek,et al.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. , 1996, The Biochemical journal.

[315]  R. Brady,et al.  Biosynthesis of bovine thyroid gangliosides. , 1978, The Journal of biological chemistry.

[316]  A. Bjourson,et al.  Siglec‐1 and ‐2 as potential biomarkers in autoimmune disease , 2016, Proteomics. Clinical applications.

[317]  N. Radin,et al.  Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain. , 1980, Chemistry and physics of lipids.

[318]  Michaela Wimmerová,et al.  Structural basis of calcium and galactose recognition by the lectin PA‐IL of Pseudomonas aeruginosa , 2003, FEBS letters.

[319]  N. Guillén,et al.  Host-Microbe Interactions and Defense Mechanisms in the Development of Amoebic Liver Abscesses , 2009, Clinical Microbiology Reviews.

[320]  H. Clausen,et al.  Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation. , 1987, The Journal of biological chemistry.

[321]  Andrew G. Watts,et al.  Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase. , 2004, Structure.

[322]  R. Zimmerman,et al.  Neuroimaging findings in late infantile GM1 gangliosidosis. , 1998, AJNR. American journal of neuroradiology.

[323]  E. Beutler Lysosomal storage diseases: natural history and ethical and economic aspects. , 2006, Molecular genetics and metabolism.

[324]  R. Rosenberg,et al.  The separation of active and inactive forms of heparin. , 1976, Biochemical and biophysical research communications.

[325]  T. Kanekura,et al.  Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease. , 2009, American journal of human genetics.

[326]  C. McGregor,et al.  Identification of New Carbohydrate and Membrane Protein Antigens in Cardiac Xenotransplantation , 2011, Transplantation.

[327]  Michael P. Snyder,et al.  Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum–associated degradation pathway , 2014, Genetics in Medicine.

[328]  Kouhei Tsumoto,et al.  Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.

[329]  R. Houlston,et al.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency , 2006, Nature Medicine.

[330]  C. McGregor,et al.  B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen , 2018, Xenotransplantation.

[331]  F. Hildebrandt,et al.  Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[332]  M. Neuberger,et al.  Deficiency in CD22, a B Cell–specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies , 1999, The Journal of experimental medicine.

[333]  S. Ishii,et al.  Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. , 2007, The Biochemical journal.

[334]  J. Sussman,et al.  X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. , 2005, The Journal of biological chemistry.

[335]  J. Callahan Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. , 1999, Biochimica et biophysica acta.

[336]  K. Campbell,et al.  Reactive oxygen species deglycosilate glomerular α-dystroglycan , 2006 .

[337]  S. Pinho,et al.  Glycosylation in cancer: mechanisms and clinical implications , 2015, Nature Reviews Cancer.

[338]  S. Withers,et al.  A New Generation of SpecificTrypanosoma cruzi trans-Sialidase Inhibitors , 2008 .

[339]  G. Boons,et al.  Synthesis of glyco(lipo)peptides by liposome-mediated native chemical ligation. , 2006, Organic letters.

[340]  A. Llebaria,et al.  New aminocyclitols as modulators of glucosylceramide metabolism. , 2005, Organic & biomolecular chemistry.

[341]  S. Hirohashi,et al.  Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. , 1998, Cancer research.

[342]  G. Matthijs,et al.  Long-term follow-up in PMM2-CDG: are we ready to start treatment trials? , 2018, Genetics in Medicine.

[343]  J. Novak,et al.  Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals , 2005, AIDS.

[344]  S. Withers,et al.  Identification of glu-277 as the catalytic nucleophile of Thermoanaerobacterium saccharolyticum beta-xylosidase using electrospray MS. , 1998, The Biochemical journal.

[345]  V. J. Stevens,et al.  Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. , 1979, Metabolism: clinical and experimental.

[346]  V. Gieselmann Metachromatic Leukodystrophy: Recent Research Developments , 2003, Journal of child neurology.

[347]  T. Hartung,et al.  Structure/function relationships of lipoteichoic acids , 2005, Journal of endotoxin research.

[348]  B. Popko,et al.  New perspectives on the function of myelin galactolipids , 1998, Trends in Neurosciences.

[349]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[350]  S. Ménard,et al.  Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. , 1983, Cancer research.

[351]  G. Hart,et al.  The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. , 1986, The Journal of biological chemistry.

[352]  T. Endo,et al.  Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan. , 2017, Biochimica et biophysica acta. General subjects.

[353]  M. Wolfert,et al.  Adaptive immune activation: glycosylation does matter. , 2013, Nature chemical biology.

[354]  L. Justement The Role of the Protein Tyrosine Phosphatase CD45 in Regulation of B Lymphocyte Activation , 2001, International reviews of immunology.

[355]  Kutty Selva Nandakumar,et al.  Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease , 2016, Nature Immunology.

[356]  K. Doran,et al.  Penetration of the blood–brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid , 2010, Journal of Molecular Medicine.

[357]  D. Hichem,et al.  生体膜におけるマイクロドメイン形成の原理 : 生細胞の細胞膜には果たして脂質 liquid ordered ドメインは存在するのか , 2008 .

[358]  M. Hollingsworth,et al.  Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. , 2010, Cancer research.

[359]  R. DeFronzo,et al.  Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM , 1996, Diabetes.

[360]  R. Bilyy,et al.  Sweet but dangerous – the role of immunoglobulin G glycosylation in autoimmunity and inflammation , 2016, Lupus.

[361]  James Theiler,et al.  Mosaic Vaccines Elicit CD8+ T lymphocyte Responses in Monkeys that Confer Enhanced Immune Coverage of Diverse HIV Strains , 2010, Nature Medicine.

[362]  J. Burchell,et al.  Macrophage–tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter‐receptor for the macrophage‐restricted receptor, sialoadhesin , 1999, Immunology.

[363]  M. Ferguson,et al.  The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. , 1999, Journal of cell science.

[364]  Tom Wennekes,et al.  Glycosphingolipide – Natur, Funktion und pharmakologische Modulierung , 2009 .

[365]  T. Sata,et al.  Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. , 1991, The American journal of pathology.

[366]  S. Pillai,et al.  Viewing Siglecs through the lens of tumor immunology , 2017, Immunological reviews.

[367]  R. Dwek,et al.  Study of the Mechanism of Antiviral Action of Iminosugar Derivatives against Bovine Viral Diarrhea Virus , 2001, Journal of Virology.

[368]  K. Sandhoff,et al.  ENZYME ALTERATIONS AND LIPID STORAGE IN THREE VARIANTS OF TAY‐SACHS DISEASE , 1971, Journal of neurochemistry.

[369]  Lori S C Kreisman,et al.  The Glycoscience of Immunity. , 2018, Trends in immunology.

[370]  R. Schrohenloher,et al.  Deficient galactosylation of serum IgG in inflammatory bowel disease: correlation with disease activity. , 1994, Journal of clinical gastroenterology.

[371]  Y. Maeda,et al.  Targeted therapy for inherited GPI deficiency. , 2007, The New England journal of medicine.

[372]  P. Johnson,et al.  Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45. , 2010, Cellular signalling.

[373]  Michael A. Hollingsworth,et al.  Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling) , 2016, Biomolecules.

[374]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[375]  A. Fogo,et al.  The glomerulus--a view from the inside--the endothelial cell. , 2010, The international journal of biochemistry & cell biology.

[376]  R. Brady,et al.  Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease , 2004, Journal of Inherited Metabolic Disease.

[377]  T. Hansen,et al.  A glycogene mutation map for discovery of diseases of glycosylation. , 2015, Glycobiology.

[378]  S. Chugh,et al.  New insights into human minimal change disease: lessons from animal models. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[379]  H. Kiyono,et al.  Epithelial glycosylation in gut homeostasis and inflammation , 2016, Nature Immunology.

[380]  G. Fleet,et al.  Inhibition of alpha-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin. , 1990, The Biochemical journal.

[381]  T. Selmer,et al.  A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency , 1995, Cell.

[382]  Kan Yang,et al.  Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.

[383]  F. Maxfield,et al.  Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors. , 2009, Biochimica et biophysica acta.

[384]  N. P. Le,et al.  Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors , 2017, The Journal of Biological Chemistry.

[385]  I. Brockhausen,et al.  The Relative Activities of the C2GnT1 and ST3Gal-I Glycosyltransferases Determine O-Glycan Structure and Expression of a Tumor-associated Epitope on MUC1* , 2001, The Journal of Biological Chemistry.

[386]  L. Guarente,et al.  RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10 , 2010, Cell.

[387]  S. Hakomori,et al.  Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. , 1984, The Journal of biological chemistry.

[388]  C. Lowrey,et al.  The effect of hemoglobin ligands on the kinetics of human hemoglobin A1c formation. , 1985, The Journal of biological chemistry.

[389]  J. Reveille,et al.  Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases , 2004, Rheumatology International.

[390]  J. Jaeken,et al.  Immunological aspects of congenital disorders of glycosylation (CDG): a review , 2016, Journal of Inherited Metabolic Disease.

[391]  Y. Niv,et al.  Mucin Function in Inflammatory Bowel Disease: An Update , 2013, Journal of clinical gastroenterology.

[392]  B. Xia,et al.  Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans , 2007, The Journal of experimental medicine.

[393]  P. Yu,et al.  O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts. , 2018, International journal of cardiology.

[394]  M. Sobrinho-Simões,et al.  Expression of fully and under‐glycosylated forms of MUC1 mucin in gastric carcinoma , 1998, International journal of cancer.

[395]  Synthesis of hemoglobin AIc in normal and diabetic mice: potential model of basement membrane thickening. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[396]  R. Cohn,et al.  Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II. , 2017, Molecular genetics and metabolism.

[397]  J. Mascola,et al.  HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure. , 2018, Immunity.

[398]  J. Nesland,et al.  Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. , 1992, APMIS. Supplementum.

[399]  R. Dwek,et al.  Exploiting the defensive sugars of HIV-1 for drug and vaccine design , 2007, Nature.

[400]  T. Dierks,et al.  Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. , 2009, Biochimica et biophysica acta.

[401]  K. Wieder,et al.  Enzyme-Polyethylene Glycol Adducts: Modified Enzymes with Unique Properties , 1978 .

[402]  H. Waldmann,et al.  Entwicklung von Inhibitoren der Tau‐Aggregation bei Morbus Alzheimer , 2009 .

[403]  M. Ferguson,et al.  Glycosylphosphatidylinositol biosynthesis validated as a drug target for African sleeping sickness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[404]  M. van der Burg,et al.  Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood. , 2016, Journal of proteome research.

[405]  K. Sandhoff,et al.  Ganglioside metabolism. Enzymology, Topology, and regulation. , 1993, The Journal of biological chemistry.

[406]  R. M. Anthony,et al.  Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease , 2017, Cell.

[407]  D. Cassiman,et al.  Nutritional Therapies in Congenital Disorders of Glycosylation (CDG) , 2017, Nutrients.

[408]  C. Allgulander,et al.  Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. , 2009, Acta medica Scandinavica.

[409]  L. Johannes,et al.  Galectins at a glance , 2018, Journal of Cell Science.

[410]  A. Reuser,et al.  Pompe's disease , 2008, The Lancet.

[411]  B. Galeano,et al.  Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. , 2007, The Journal of clinical investigation.

[412]  A. Heck,et al.  Crosstalk between phosphorylation and O‐GlcNAcylation: friend or foe , 2018, The FEBS journal.

[413]  S. Zographos,et al.  Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition. , 2006, Journal of medicinal chemistry.

[414]  R. Wattiaux,et al.  Identification of HE1 as the second gene of Niemann-Pick C disease. , 2000, Science.

[415]  V. Viallon,et al.  Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). , 2011, Arthritis and rheumatism.

[416]  A. Imberty,et al.  Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I. , 2008, Journal of molecular biology.

[417]  D. van Schaardenburg,et al.  Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis , 2013, Annals of the rheumatic diseases.

[418]  K. Tryggvason,et al.  Identification of N-linked glycosylation sites in human nephrin using mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[419]  M. Hegde,et al.  Glycosylation, hypogammaglobulinemia, and resistance to viral infections. , 2014, The New England journal of medicine.

[420]  M. McConville,et al.  The major surface antigens of Entamoeba histolytica trophozoites are GPI-anchored proteophosphoglycans. , 2000, Journal of molecular biology.

[421]  T. Yamaji,et al.  CERT-mediated trafficking of ceramide. , 2009, Biochimica et biophysica acta.

[422]  K. Matsui,et al.  Valiolamine, a new alpha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. , 1984, Journal of antibiotics (Tokyo. 1968).

[423]  B. Julian,et al.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy , 2016, Front. Immunol..

[424]  R. Ueda,et al.  Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[425]  B. Xia,et al.  Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. , 2008, Cancer research.

[426]  Gregory A Petsko,et al.  Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. , 2006, Nature chemical biology.

[427]  S. Ishii,et al.  Hydrophilic iminosugar active‐site‐specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients , 2006, The FEBS journal.

[428]  M. Jäättelä,et al.  Lysosomal involvement in cell death and cancer. , 2009, Biochimica et biophysica acta.

[429]  Egbert Tannicht Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction , 1998 .

[430]  E. Yang,et al.  ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage , 2017, The Journal of Biological Chemistry.

[431]  S. Cascio,et al.  Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis , 2016, Biomolecules.

[432]  R. Schiffmann,et al.  Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease , 2000 .

[433]  A. Varki,et al.  Endothelial Heparan Sulfate Proteoglycans That Bind to L-Selectin Have Glucosamine Residues with Unsubstituted Amino Groups (*) , 1995, The Journal of Biological Chemistry.

[434]  Matthew Might,et al.  Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches , 2018, Human molecular genetics.

[435]  Kim Vo,et al.  Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. , 2011, Glycobiology.

[436]  S M Lewis,et al.  Natural history of paroxysmal nocturnal hemoglobinuria. , 1995, The New England journal of medicine.

[437]  Joseph Sodroski,et al.  Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry , 1999, Cell.

[438]  O. Schneewind,et al.  Genes Required for Glycolipid Synthesis and Lipoteichoic Acid Anchoring in Staphylococcus aureus , 2007, Journal of bacteriology.

[439]  N. Barzilai,et al.  A nutrient-sensing pathway regulates leptin gene expression in muscle and fat , 1998, Nature.

[440]  D. Scott,et al.  Endothelial Surface N-Glycans Mediate Monocyte Adhesion and Are Targets for Anti-inflammatory Effects of Peroxisome Proliferator-activated Receptor γ Ligands* , 2011, The Journal of Biological Chemistry.

[441]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[442]  Jian‐Qiang Fan,et al.  A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity , 2008, Biological chemistry.

[443]  C. Willey,et al.  Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death , 2018, Journal of Ovarian Research.

[444]  K. Yan,et al.  N-linked glycosylation is critical for the plasma membrane localization of nephrin. , 2002, Journal of the American Society of Nephrology : JASN.

[445]  F. Lang,et al.  Human Acid Ceramidase , 2001, The Journal of Biological Chemistry.

[446]  V. Apostolopoulos,et al.  Cellular Mucins: Targets for Immunotherapy. , 2017, Critical reviews in immunology.

[447]  D. Horn,et al.  A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes , 2008, Proceedings of the National Academy of Sciences.

[448]  M. Nozaki,et al.  Developmental abnormalities of glycosylphosphatidylinositol-anchor-deficient embryos revealed by Cre/loxP system. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[449]  P. van Paassen,et al.  Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis , 2017, EBioMedicine.

[450]  M. Farquhar,et al.  Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion , 1980, The Journal of cell biology.

[451]  Paul W Smith,et al.  Inhibition of HIV replication by amino‐sugar derivatives , 1988, FEBS letters.

[452]  K. Sandhoff,et al.  The c-series gangliosides GT3, GT2 and GP1c are formed in rat liver Golgi by the same set of glycosyltransferases that catalyse the biosynthesis of asialo-, a- and b-series gangliosides. , 1992, Glycobiology.

[453]  S. Withers,et al.  Structural and Mechanistic Analyses of endo-Glycoceramidase II, a Membrane-associated Family 5 Glycosidase in the Apo and GM3 Ganglioside-bound Forms* , 2007, Journal of Biological Chemistry.

[454]  F. Gianfrancesco,et al.  Dysregulation of the Expression of Asparagine-Linked Glycosylation 13 Short Isoform 2 Affects Nephrin Function by Altering Its N-Linked Glycosylation , 2017, Nephron.

[455]  Jeffrey D. Esko,et al.  Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.

[456]  A. Hidrón,et al.  Chagas disease: an impediment in achieving the Millennium Development Goals in Latin America , 2007, BMC international health and human rights.

[457]  J. Nielsen,et al.  Novel functions of the CD34 family , 2008, Journal of Cell Science.

[458]  H. Kunz,et al.  Ein synthetischer Impfstoff aus einem tumorassoziierten Sialyl‐TN‐MUC1‐Tandem‐Repeat‐Glycopeptid und Tetanustoxoid zur Induktion einer starken, hochselektiven Immunantwort , 2009 .

[459]  J. Waltenberger,et al.  The Molecular Basis of VEGFR-1 Signal Transduction Pathways in Primary Human Monocytes , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[460]  L. Callahan,et al.  Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions , 1991, Journal of virology.

[461]  Takurou Kobayashi,et al.  The twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease) , 1980, Brain Research.

[462]  P. Frenette,et al.  The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies. , 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[463]  J. Marth,et al.  Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.

[464]  H. Lortat-Jacob,et al.  The HIV-1 Envelope Glycoprotein gp120 Features Four Heparan Sulfate Binding Domains, Including the Co-receptor Binding Site* , 2008, Journal of Biological Chemistry.

[465]  T. Barbui,et al.  Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin. , 2008, Thrombosis research.

[466]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[467]  R. Schnaar,et al.  Glycobiology simplified: diverse roles of glycan recognition in inflammation , 2016, Journal of leukocyte biology.

[468]  H. Sakuraba,et al.  Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement. , 2006, Glycobiology.

[469]  Evan Bolton,et al.  Symbol Nomenclature for Graphical Representations of Glycans. , 2015, Glycobiology.

[470]  T. Okamoto,et al.  In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. , 2008, Bioorganic & medicinal chemistry.

[471]  Kai Simons,et al.  Cholesterol, lipid rafts, and disease. , 2002, The Journal of clinical investigation.

[472]  Thomas Kolter,et al.  Sphingolipide – ihre Stoffwechselwege und die Pathobiochemie neurodegenerativer Erkrankungen , 1999 .

[473]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[474]  T. Irimura,et al.  Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. , 1984, The Journal of biological chemistry.

[475]  J. Houwing-Duistermaat,et al.  Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health , 2017, Scientific Reports.

[476]  P. Berman,et al.  Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies , 2018, PloS one.

[477]  H. Hauri,et al.  Mutations in the ER–Golgi Intermediate Compartment Protein ERGIC-53 Cause Combined Deficiency of Coagulation Factors V and VIII , 1998, Cell.

[478]  S. Ellenberg,et al.  CEA Monitoring Among Patients in Multi‐institutional Adjuvant G.I. Therapy Protocols , 1982, Annals of surgery.

[479]  S. Targan,et al.  Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases. , 2018, Gastroenterology.

[480]  Jung Weon Lee,et al.  O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. , 2008, Experimental cell research.

[481]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[482]  D. Lockhart,et al.  The pharmacological chaperone 1-deoxygalactonojirimycin increases α-galactosidase A levels in Fabry patient cell lines , 2009, Journal of Inherited Metabolic Disease.

[483]  R Shapiro,et al.  Sites of nonenzymatic glycosylation of human hemoglobin A. , 1980, The Journal of biological chemistry.

[484]  D. James,et al.  Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro , 2005, Biotechnology progress.

[485]  Karin Milde-Langosch,et al.  Role of protein glycosylation in cancer metastasis. , 2017, Seminars in cancer biology.

[486]  V. Blanchard,et al.  Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis , 2018, Front. Immunol..

[487]  A. Paguio,et al.  ABO blood groups and cholera. , 1977, Annals of human biology.

[488]  J. Chatham,et al.  O-GlcNAcylation and cardiovascular disease. , 2017, Biochemical Society transactions.

[489]  Yinying Wu,et al.  Anti-angiogenesis and anti-tumor effects of AdNT4-anginex. , 2009, Cancer letters.

[490]  R. Rodeheffer,et al.  The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota. , 2014, Journal of cardiac failure.

[491]  J. Peter-Katalinic,et al.  High Density O-Glycosylation on Tandem Repeat Peptide from Secretory MUC1 of T47D Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[492]  Jeanine J. Houwing-Duistermaat,et al.  Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers , 2013, PLoS genetics.

[493]  G. Alarcón,et al.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. , 2008, The Journal of clinical investigation.

[494]  Y. Jigami,et al.  Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice , 2006, Journal of Human Genetics.

[495]  J. Kawabata,et al.  Alpha-glucosidase inhibitory effect of mulberry (Morus alba) leaves on Caco-2. , 2006, Fitoterapia.

[496]  Satoshi Ishii,et al.  Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor , 1999, Nature Medicine.

[497]  Y. Hannun,et al.  Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.

[498]  Renato V. Iozzo,et al.  Proteoglycan form and function: A comprehensive nomenclature of proteoglycans , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[499]  D. Cooper,et al.  The need for xenotransplantation as a source of organs and cells for clinical transplantation. , 2015, International journal of surgery.

[500]  A. Deelder,et al.  Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation. , 2015, Journal of proteome research.

[501]  K. Ohshima,et al.  Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[502]  R. Griffin,et al.  Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models , 2017, International journal of molecular sciences.

[503]  Minyoung Lee,et al.  Increasing the α 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer , 2013, Gut and liver.

[504]  D. Bullard,et al.  The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype. , 2016, Cancer research.

[505]  M. Kris,et al.  Vaccination of Patients with Small-Cell Lung Cancer with Synthetic Fucosyl GM-1 Conjugated to Keyhole Limpet Hemocyanin , 2004, Clinical Cancer Research.

[506]  M. Cragg,et al.  Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering , 2017, BioDrugs.

[507]  Dapeng Zhou The immunological function of iGb3. , 2006, Current protein & peptide science.

[508]  R. Dwek,et al.  N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. , 1994, The Journal of biological chemistry.

[509]  J. Ravetch,et al.  A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs , 2010, Journal of Clinical Immunology.

[510]  S. Sonnino,et al.  Saposin B binds and transfers phospholipids Published, JLR Papers in Press, February 6, 2006. , 2006, Journal of Lipid Research.

[511]  V. Dotz,et al.  Histo-blood group glycans in the context of personalized medicine☆ , 2015, Biochimica et Biophysica Acta (BBA) - General Subjects.

[512]  M. Beck New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy , 2007, Human Genetics.

[513]  Thierry Hennet,et al.  Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction. , 2015, Trends in biochemical sciences.

[514]  A. Paterson,et al.  Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[515]  S. Brodie,et al.  A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. , 2001, American journal of human genetics.

[516]  D. Atha,et al.  Contribution of monosaccharide residues in heparin binding to antithrombin III. , 1985, Biochemistry.

[517]  C. Kensil,et al.  Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. , 1991, Journal of immunology.

[518]  P. Moore The Neutralizing Antibody Response to the HIV-1 Env Protein. , 2017, Current HIV research.

[519]  G. Matthijs,et al.  Congenital disorders of glycosylation (CDG): Quo vadis? , 2017, European journal of medical genetics.

[520]  M. Wolfert,et al.  Increasing the Antigenicity of Synthetic Tumor‐Associated Carbohydrate Antigens by Targeting Toll‐Like Receptors , 2009, Chembiochem : a European journal of chemical biology.

[521]  R. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.

[522]  Anant K. Menon,et al.  Thematic review series: Lipid Posttranslational Modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids Published, JLR Papers in Press, March 14, 2007. , 2007, Journal of Lipid Research.